Venus Remedies Q2FY17

1. Net profit down 31.3% at Rs 1.1 cr v/s Rs 1.6 cr (YoY) 
2. Total income up 1.1% at Rs 107.1 cr v/s Rs 105.9 cr (YoY) 
3. EBITDA down 4.9% at Rs 19.3 cr v/s Rs 20.3 cr (YoY)
4. EBITDA margin at 18% v/s 19.3% (YoY)